About this paper
Design of experiment (DOE) was utilized to optimize a peptide microarray to test autoantibodies in serum against various components of the myelin sheath. Incorporating the ideal assay conditions from a single DOE experiment versus multiple sequential experiments resulted in a reproducible serum assay with low variability, low nonspecific background, and a high level of distinction between multiple sclerosis (MS) and normal samples. A minimum set of peptides was found that achieved a sensitivity of 90 percent. Autoantibodies against each individual peptide were elevated in at least 35 percent of the individual MS patients tested.
Acerca de SAS
SAS es la compañía líder de software y servicios de Business Analytics, y el mayor proveedor independiente del mercado de Business Intelligence. A través de soluciones innovadoras, SAS ayuda a clientes en más de 80.000 instalaciones a mejorar el rendimiento y crear valor con una toma de decisiones más rápida. Desde 1976, SAS proporciona a sus clientes en todo el mundo THE POWER TO KNOW®.
¿Tiene un Perfil SAS? Para completar este formulario automáticamente Ingreso